Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at docetaxel and saracatinib for prostate cancer that has spread (SAPROCAN)

Overview

Cancer types:

Prostate cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is looking at docetaxel and saracatinib for prostate cancer that has continued to grow despite other treatment and has spread outside the prostate. This trial is supported by Cancer Research UK.

Recruitment start: 16 October 2013

Recruitment end: 30 April 2016

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Rob J Jones

Supported by

AstraZeneca

Beatson Oncology Centre

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

NHS Greater Glasgow and Clyde

NIHR Clinical Research Network: Cancer

University of Glasgow

Other information

This is Cancer Research UK trial number CRUKE/10/043.

Last reviewed: 29 April 2016

CRUK internal database number: 6192

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.